Since the first of the year, the momentum in Latin America’s decade-long GMO commercialisation debate has shifted toward acceptance. With the exception of Argentina, legislative deadlocks have blocked passage of comprehensive biosafety laws. As a result, approval will likely be achieved via federal court rulings and the issuance of official ministerial norms, reports Steve Lewis.